Affiliation:
1. Department of Pharmacology, Faculty of Pharmacy, Mutah University, P.O. Box 7, Al-Karak 61710, Jordan
2. Department of Botany and Microbiology, Faculty of Science, Al-Azhar University, Girls Branch, Cairo 11754, Egypt
3. Department of Pharmacology, Faculty of Medicine, Mutah University, P.O. Box 7, Al-Karak 61710, Jordan
Abstract
Tephorosia purpurea subsp. apollinea was extracted with methanol and n-hexane to obtain sub-fractions. The chemical compounds identified with GC-MS and HPLC in T. purpurea subsp. apollinea extracts showed antioxidant and anticancer properties. The antioxidant and anticancer activities were investigated using DDPH and ABTS assays, and MTT assay, respectively. Stigmasta-5,24(28)-dien-3-ol, (3 β,24Z)-, 9,12,15-octadecatrienoic acid methyl ester, phytol, chlorogenic acid, and quercetin were the major chemical compounds detected in T. purpurea subsp. apollinea. These compounds possessed antioxidant and anticancer properties. The methanol extract showed antioxidant properties with DDPH and ABTS radical scavenging of 84% and 94%, respectively, relative to ascorbic acid and trolox. The anticancer effects of T. purpurea subsp. apollinea against the cancer cell lines MCF7 (IC50 = 102.8 ± 0.6 μg/mL), MG63 (IC50 = 118.3 ± 2.5 μg/mL), T47D (IC50 = 114.7 ± 1.0 μg/mL), HeLa (IC50 = 196.3 ± 2.3 μg/mL), and PC3 (IC50 = 117.7 ± 1.1 μg/mL) were greater than its anticancer effects against U379 (IC50 = 248.4 ± 7.5 μg/mL). However, it had no adverse effects on the normal cells (WI38) (IC50 = 242.9 ± 1.8 μg/mL). Therefore, the major active constituents presented in T. purpurea subsp. apollinea can be isolated and studied for their potential antioxidant and anticancer effects against breast, cervical, and prostate cancers and osteosarcoma.
Subject
Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science
Reference82 articles.
1. Cancer and radiation therapy: Current advances and future directions;Baskar;Int. J. Med. Sci.,2012
2. Profiling of CYP4Z1 and CYP1B1 expression in bladder cancers;Alshammari;Sci. Rep.,2021
3. Yang, C., Mai, Z., Liu, C., Yin, S., Cai, Y., and Xia, C. (2022). Natural products in preventing tumor drug resistance and related signaling pathways. Molecules, 27.
4. Cytochrome 4Z1 expression is correlated with poor prognosis in patients with cervical cancer;Alshammari;Curr. Oncol.,2021
5. Screening of glypican-6 expression in benign, primary and metastatic colon cancers;Alshammari;Clin. Med. Insights Oncol.,2021
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献